ELTX: Elicio Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 84.48
Enterprise Value ($M) 86.16
Book Value ($M) 8.90
Book Value / Share 0.56
Price / Book 9.49
NCAV ($M) 1.70
NCAV / Share 0.11
Price / NCAV 49.84

Profitability (mra)
Return on Invested Capital (ROIC) -1.47
Return on Assets (ROA) -2.09
Return on Equity (ROE) -10.53

Liquidity (mrq)
Quick Ratio 1.83
Current Ratio 1.83

Balance Sheet (mrq) ($M)
Current Assets 20.93
Assets 28.14
Liabilities 19.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -44.99
Net Income -51.90

Cash Flow Statement (mra) ($M)
Cash From Operations -37.07
Cash from Investing -0.08
Cash from Financing 42.32

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
3 days ago 13G/A Actyus Private Equity SGIIC, S.A. 5.40 45.69
03-07 13D/A Yekaterina Chudnovsky 48.10
02-05 13G Knoll Capital Management, LLC 5.20
08-14 13D/A Gkcc, Llc 38.70 159.90

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-15 786 7,205 10.91
2025-05-14 8,894 33,010 26.94
2025-05-13 1,216 14,721 8.26
2025-05-12 3,583 6,723 53.29

(click for more detail)

Similar Companies
EDSA – Edesa Biotech, Inc. ELDN – Eledon Pharmaceuticals, Inc.
ELEV – Elevation Oncology, Inc. ELUT – Elutia Inc.
ENLV – Enlivex Therapeutics Ltd.


Financial data and stock pages provided by
Fintel.io